Lv13
28 积分 2024-07-31 加入
IL-23 inhibition for chronic inflammatory disease
1天前
已完结
Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy
1天前
已完结
Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling
1天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
1天前
已完结
Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies
1天前
已完结
Differential requirement for IL-2 and IL-23 in the differentiation and effector functions of Th17/ILC3-like cells in a human T cell line
1天前
已完结
Frozen, but no accident – why the 20 standard amino acids were selected
7天前
已完结
TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders
9天前
已完结
Therapeutic Potential of Tulisokibart and Anti-TL1A Therapy in Inflammatory Disorders: Current Insights and Future Directions
9天前
已完结
Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis
9天前
已完结
皖公网安备34019202002308
